Aeton Therapeutics
UEI: MC2DMP4NVUC7
• CAGE: 81S25
Overview
Awardee Type
Parent
Name
Aeton Therapeutics
Headquarters
Sarasota, FL
United States
United States
Most Recent Award
Sept. 15, 2024
Calculating
Federal grant recipient
AETON THERAPEUTICS INC.
(UEI MC2DMP4NVUC7, CAGE 81S25)
is headquartered in Sarasota FL.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in January 2018 and
federally registered in
February 2018.
Federal Award Analysis
Aeton Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
AETON THERAPEUTICS INC.
UEI
MC2DMP4NVUC7
CAGE Code
81S25
Primary NAICS
SBA Certifications
None
Self Certifications
Woman Owned Business
Woman Owned Small Business
Woman Owned Small Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 12, 2018
Initial Registration
Feb. 8, 2018
Last Registration
Jan. 23, 2025
Registration Activation
Jan. 23, 2025
Registration Expiration
Jan. 21, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No